Cargando…
Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancer
Lung cancer is the leading cause of cancer-related deaths in the United States with non-small cell lung cancer (NSCLC) accounting for most cases. Despite advances in cancer therapeutics, the 5-year survival rate has remained poor due to several contributing factors, including its resistance to thera...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Gene & Cell Therapy
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995506/ https://www.ncbi.nlm.nih.gov/pubmed/36911069 http://dx.doi.org/10.1016/j.omto.2023.02.007 |